Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Lohmann

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial ExperiencesNorbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Neuro-Oncology Practice|May 14, 2026
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research projectEvangelia Razis, Thierry Gorlia, Matthias Preusser, et al.
Nuklearmedizin. Nuclear Medicine|June 2, 2026
German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025)Ralph Buchert, Philipp T Meyer, Nathalie L Albert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practiceSpyridon Bakas, Philipp Vollmuth, Norbert Galldiks, et al.
The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancementsJavier E Villanueva-Meyer, Spyridon Bakas, Pallavi Tiwari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic gliomaJan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
AJNR. American Journal of Neuroradiology|August 8, 2025
ASNR Consensus Statement: Integrating Neuro-PET Interpretation into Neuroradiology Training and PracticeJana Ivanidze, Ana M Franceschi, Max Wintermark, et al.
The Lancet. Oncology|July 31, 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomasNorbert Galldiks, Philipp Lohmann, Mariam Aboian, et al.
Cancers|July 27, 2022
Two Decades of Brain Tumour Imaging with O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich ExperienceAlexander Heinzel, Daniela Dedic, Norbert Galldiks, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using <sup>18</sup>F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial ExperiencesNorbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.
Neuro-Oncology Practice|May 14, 2026
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research projectEvangelia Razis, Thierry Gorlia, Matthias Preusser, et al.
Nuklearmedizin. Nuclear Medicine|June 2, 2026
German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025)Ralph Buchert, Philipp T Meyer, Nathalie L Albert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practiceSpyridon Bakas, Philipp Vollmuth, Norbert Galldiks, et al.
The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancementsJavier E Villanueva-Meyer, Spyridon Bakas, Pallavi Tiwari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic gliomaJan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
AJNR. American Journal of Neuroradiology|August 8, 2025
ASNR Consensus Statement: Integrating Neuro-PET Interpretation into Neuroradiology Training and PracticeJana Ivanidze, Ana M Franceschi, Max Wintermark, et al.
The Lancet. Oncology|July 31, 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomasNorbert Galldiks, Philipp Lohmann, Mariam Aboian, et al.
Cancers|July 27, 2022
Two Decades of Brain Tumour Imaging with O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich ExperienceAlexander Heinzel, Daniela Dedic, Norbert Galldiks, et al.
Pageof 14